3-D Matrix, Ltd. (TYO:7777)

Market Cap	33.48B
Revenue (ttm)	7.64B
Net Income (ttm)	-949.00M
Shares Out	114.26M
EPS (ttm)	-8.98
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,951,700
Average Volume	6,364,075
Open	303.00
Previous Close	298.00
Day's Range	293.00 - 308.00
52-Week Range	99.00 - 348.00
Beta	0.10
RSI	57.70
Earnings Date	Sep 11, 2025

About 3-D Matrix

3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.